Received Oct 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Rash; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Herpes Zoster vaccine) for prophylaxis. On an unknown date, the patient received Herpes Zoster vaccine. On an unknown date, an unknown time after receiving Herpes Zoster vaccine, the patient experienced rash (Verbatim: Rash). The outcome of the rash was not reported. It was unknown if the reporter considered the rash to be related to Herpes Zoster vaccine. It was unknown if the company considered the rash to be related to Herpes Zoster vaccine. Additional Information: GSK Receipt Date: 03-SEP-2025 The patient had rash and asked if soap or body make it worse. Patient asked if Benadryl help or not.